Skip to Content
Stream Live
More Streaming Options
ON AIR
Recently Played
View Full Playlist
SUPPORT
‹ All Events

Biosimilars in the EU MasterClass

SUPPORT

The market share of drug products manufactured by means of modern biotechnology is constantly increasing. In Germany, it is close to 25% in value. This means that there will be a major cost saving potential for the healthcare systems by introduction of Biosimilar competition. New therapeutic options are opened for treatment of severe medical conditions and it is obvious that this product category will become even more important in the future. Consequently, it is vital for generic pharmaceutical companies to consider extending their business scope from drug products with classical chemically synthetized API to Biosimilars. The training aims to create deeper understanding why biotechnological products – and as a consequence biosimilars – are a unique product category and what aspects have to be considered in R&D and Drug Regulatory Affairs.

More Lectures & Presentations

GED Virtual Classroom Onboarding
Every Monday | 11:00 am - 12:00 pm
Online
Founding Mothers: From the Ballot Box to the University-Online exhibit
November 2 - May 29, 2021
Online-University of Arizona Libraries, Special Collections
Director’s Choice reading from the 1970s: Adrienne Rich
Director’s Choice reading from the 1970s: Adrienne Rich
October 13 - November 25 | 5:00 pm
Online
Healthcare automation from Machine Learning to AI MasterClass
Healthcare automation from Machine Learning to AI MasterClass
December 9 - December 11, 2020 | 9:00 am - 5:00 pm
Online Event
Next Generation Agile Performance Management (PM) Masterclass
Next Generation Agile Performance Management (PM) Masterclass
December 2 - December 3, 2020 | 9:00 am - 5:00 pm
Online Event

More Events

KXCI NEWSLETTER

Sign Up

SUPPORT
LOCAL RADIO

SUPPORT